Standout Papers

SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice h... 2019 2026 2021 2023 427
  1. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart (2019)
    Chenguang Li, Jie Zhang et al. Cardiovascular Diabetology

Immediate Impact

1 from Science/Nature 54 standout
Sub-graph 1 of 22

Citing Papers

Role of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabetes
2024 Standout
New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications
2024 Standout
2 intermediate papers

Works of Ting Li being referenced

SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
2019 Standout

Author Peers

Author Last Decade Papers Cites
Ting Li 130 238 152 315 267 68 932
Esmeralda Castelblanco 162 126 68 304 401 68 1.0k
Takako Nagai 121 195 58 364 288 34 1.1k
Iacopo Panarese 148 124 67 284 110 41 846
Tomasz Francuz 113 139 52 300 193 63 778
Takuya Ishikawa 116 259 59 255 145 38 939
Yefeng Cai 200 175 72 368 314 61 1.0k
Wei Li 179 128 121 410 205 69 1.0k
Giuseppe Santeusanio 85 160 60 188 188 64 952
Shohei Ogoshi 59 359 108 315 85 61 1.2k
Ken-ichiro Tanaka 77 176 65 490 163 35 1.1k

All Works

Loading papers...

Rankless by CCL
2026